Serum bactericidal activity of aztreonam, cefoperazone, and amikacin, alone or in combination, against Escherichia coli, Klebsiella pneumoniae, Serratia marcescens, and Pseudomonas aeruginosa
- 1 August 1984
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 26 (2) , 224-227
- https://doi.org/10.1128/aac.26.2.224
Abstract
Serum samples from volunteers receiving (per kilogram) 20 mg of aztreonam, 20 mg of cefoperazone, 7.5 mg of amikacin, 20 mg of cefoperazone plus 20 mg of aztreonam, or 20 mg of aztreonam plus 7.5 mg of amikacin were evaluated for bactericidal activity against Escherichia coli, Klebsiella pneumonia, Serratia marcescens, and Pseudomonas aeruginosa. Serum bactericidal activities were similar for aztreonam alone or in combination but were lower for amikacin and cefoperazone alone, especially against S. marcescens and P. aeruginosa. Killing studies, performed with serum samples diluted 1:8, demonstrated a high killing rate for aztreonam plus amikacin, especially against P. aeruginosa.Keywords
This publication has 4 references indexed in Scilit:
- Synergistic Combinations of Antibiotics in Gram-Negative Bacillary InfectionsClinical Infectious Diseases, 1982
- Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteriaAntimicrobial Agents and Chemotherapy, 1982
- Serum Dilution Test for Bactericidal Activity. II. Standardization and Correlation with Antimicrobial Assays and Susceptibility TestsThe Journal of Infectious Diseases, 1977
- Use of Sodium Polyanethol Sulfonate to Selectively Inhibit Aminoglycoside and Polymyxin Antibiotics in a Rapid Blood Level Antibiotic AssayAntimicrobial Agents and Chemotherapy, 1976